Gilead Sciences Inc (GILD)
76.08
-0.12
(-0.16%)
USD |
NASDAQ |
Jun 07, 16:00
76.08
0.00 (0.00%)
After-Hours: 20:00
Gilead Sciences Price: 76.08 for June 7, 2023
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Jun 07, 2023 | 76.15 | 76.23 | 75.12 | 76.08 | 6.981M |
Jun 06, 2023 | 78.29 | 78.43 | 76.02 | 76.20 | 5.408M |
Jun 05, 2023 | 77.82 | 78.03 | 77.18 | 77.72 | 5.744M |
Jun 02, 2023 | 76.12 | 77.98 | 75.80 | 77.89 | 4.877M |
Jun 01, 2023 | 77.54 | 77.54 | 75.87 | 76.21 | 5.031M |
May 31, 2023 | 76.62 | 77.02 | 76.27 | 76.94 | 8.073M |
May 30, 2023 | 76.52 | 76.87 | 76.01 | 76.33 | 5.038M |
May 26, 2023 | 78.00 | 78.62 | 77.01 | 77.09 | 5.439M |
May 25, 2023 | 77.47 | 78.18 | 76.26 | 77.65 | 8.118M |
May 24, 2023 | 79.12 | 79.26 | 78.14 | 79.05 | 5.864M |
May 23, 2023 | 78.60 | 79.56 | 78.10 | 78.58 | 4.543M |
May 22, 2023 | 79.30 | 79.85 | 78.40 | 78.62 | 3.560M |
May 19, 2023 | 78.78 | 79.62 | 78.65 | 78.84 | 5.694M |
May 18, 2023 | 78.88 | 79.05 | 77.36 | 78.21 | 5.050M |
May 17, 2023 | 78.14 | 79.02 | 77.05 | 78.81 | 5.507M |
May 16, 2023 | 79.77 | 79.77 | 78.16 | 78.32 | 5.765M |
May 15, 2023 | 78.07 | 78.40 | 77.83 | 78.38 | 2.723M |
May 12, 2023 | 78.77 | 79.08 | 77.91 | 78.17 | 3.519M |
May 11, 2023 | 78.16 | 78.76 | 77.45 | 78.70 | 5.124M |
May 10, 2023 | 78.77 | 78.84 | 77.16 | 78.11 | 5.614M |
May 09, 2023 | 78.31 | 79.28 | 78.30 | 78.80 | 4.547M |
May 08, 2023 | 79.61 | 79.66 | 78.13 | 78.59 | 3.824M |
May 05, 2023 | 78.75 | 79.83 | 78.22 | 79.75 | 4.614M |
May 04, 2023 | 79.61 | 79.68 | 78.41 | 78.52 | 4.564M |
May 03, 2023 | 80.49 | 80.90 | 79.12 | 79.45 | 5.058M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
56.65
Minimum
Dec 30 2020
89.47
Maximum
Dec 08 2022
69.13
Average
67.28
Median
Price Benchmarks
Johnson & Johnson | 158.52 |
Pfizer Inc | 38.89 |
AbbVie Inc | 136.50 |
Merck & Co Inc | 108.61 |
Bristol-Myers Squibb Co | 65.16 |
Price Related Metrics
PE Ratio | 17.17 |
PS Ratio | 3.550 |
PEG Ratio | 0.7233 |
Price to Book Value | 4.520 |
Price to Free Cash Flow | 11.45 |
Earnings Yield | 5.82% |
Market Cap | 94.90B |
PEGY Ratio | 0.6221 |
Operating PE Ratio | 7.410 |
Normalized PE Ratio | 10.88 |